Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on October 7, 2026, disclosing that it has entered into a material definitive agreement.
- 8-K - Onfolio Holdings, Inc (0001825452) (Filer)
Onfolio Holdings filed an 8-K reporting a notice of delisting or failure to meet a continued listing rule and a transfer of its listing, along with other events and accompanying financial statements and exhibits.
- 8-K - BioCardia, Inc. (0000925741) (Filer)
BioCardia, Inc. filed a Form 8-K with the SEC on October 7, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NEOGEN CORP (0000711377) (Filer)
NeoGen Corp filed an 8-K on October 7, 2026, including Item 5.07 regarding submission of matters to a vote of security holders and Item 9.01 containing financial statements and related exhibits.
- 8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)
Bitmine Immersion Technologies, Inc. filed a Form 8-K with the SEC on October 7, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - AIB Data Centers Inc. (0002070542) (Filer)
AIB Data Centers Inc. filed a Form 8-K on October 7, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - Ellington Financial Inc. (0001411342) (Filer)
Ellington Financial Inc. filed a Form 8-K on October 7, 2026, reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.
- 8-K - Ellington Credit Co (0001560672) (Filer)
Ellington Credit Co filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001628280-26-065295.
- 8-K - TaoWeave, Inc. (0000746210) (Filer)
TaoWeave, Inc. filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Launch Two Acquisition Corp. (0002023676) (Filer)
Launch Two Acquisition Corp. filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)
CERO Therapeutics Holdings, Inc. filed a Form 8-K on October 7, 2026, disclosing entry into a material definitive agreement and including its financial statements and accompanying exhibits.
- 8-K - Beeline Holdings, Inc. (0001534708) (Filer)
Beeline Holdings, Inc. filed a Form 8-K on October 7, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Item 7.01 and Item 9.01.
- 8-K - BILI Social International, Inc. (0001109262) (Filer)
BILI Social International, Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on October 7, 2026, with accession number 0001683168-26-007679, comprising 186 KB of information.
- 8-K - Charlton Aria Acquisition Corp (0002024459) (Filer)
Charlton Aria Acquisition Corp filed a Form 8-K on October 7, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - OpenWorld, Inc. (0001104038) (Filer)
OpenWorld, Inc. filed a Form 8-K with the SEC on October 7, 2026, containing a Regulation FD disclosure and the company's financial statements and related exhibits.
- 8-K - MEXICO FUND INC (0000065433) (Filer)
Mexico Fund Inc filed a Form 8-K on October 7, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - FUELCELL ENERGY INC (0000886128) (Filer)
FuelCell Energy Inc. filed an 8-K reporting the departure, election, and appointment of certain directors or officers, along with related compensatory arrangements, and included its financial statements and accompanying exhibits.
- 8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)
Jasper Therapeutics, Inc. filed a Form 8-K on October 7 2026 (Accession No. 0001213900-26-107402) containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - SRX Global Inc. (0001471727) (Filer)
SRX Global Inc. filed a Form 8-K on October 7, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - WillScot Holdings Corp (0001647088) (Filer)
WillScot Holdings Corp filed a Form 8-K on Oct. 7, 2026, reporting departures, elections, appointments and related compensation arrangements for certain officers, and providing a Regulation FD disclosure.
- 8-K - Azenta, Inc. (0000933974) (Filer)
Azenta, Inc. filed a Form 8-K on October 7 2026, disclosing costs associated with exit or disposal activities, material impairments, and providing its financial statements and related exhibits.
- 8-K - LogicMark, Inc. (0001566826) (Filer)
LogicMark, Inc. filed a Form 8-K on October 7, 2026 (Accession No. 0001213900-26-107400) indicating that certain matters were submitted to a vote of its security holders.
- 8-K - Dalrada Technology Group, Inc. (0000725394) (Filer)
Dalrada Technology Group filed an 8-K reporting entry into and termination of material definitive agreements, other events, and accompanying financial statements and exhibits.
- 8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Spyre Therapeutics filed a Form 8-K on October 7, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - AVAX ONE TECHNOLOGY LTD. (0001826397) (Filer)
Avax One Technology Ltd. filed a Form 8-K on October 7, 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - Safe Pro Group Inc. (0002011208) (Filer)
Safe Pro Group Inc. filed a Form 8-K on October 7, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).
- Department of Justice Announces Phase Three of Compensation Process for Western Union Fraud Victims
The U.S. Department of Justice announced the start of phase three of its remission compensation process aimed at providing recovery to victims of Western Union fraud.
- Heal 360 Clinics and Owner Agree to Pay $20M to Resolve False Claims Act Allegations of Billing False Claims to the COVID-19 Uninsured Program for Services Not Rendered
Heal 360 Urgent Care PLLC, Heal 360 Primary Care PLLC and owner Dr. Mohammed Amer Mohiuddin agreed to pay $20 million to settle False Claims Act allegations of submitting false COVID-19 uninsured program claims for services not rendered.
- Known Cybersecurity Expert and Owner of Florida Ransomware Remediation Company Charged with Defrauding Clients
Zohar Pinhasi, a 50-year-old U.S. and Israeli national also known as “Zack Silver” and “Zack Green,” was arraigned in the Eastern District of New York on wire-fraud charges for allegedly misrepresenting his ability to decrypt ransomware without paying cybercriminals.
- Board Chairman and Co-Owner of Puerto Rican Bank Sentenced in Multimillion-Dollar Wire Fraud Conspiracy
The former board chairman and co-owner of Nodus International Bank was sentenced by a federal court to 62 months in prison, three years of supervised release and forfeiture of approximately $13.6 million derived from a wire-fraud conspiracy.